As of 2024-12-12, the Intrinsic Value of Life Science REIT PLC (LABS.L) is
34.51 GBP. This LABS.L valuation is based on the model Discounted Cash Flows (Growth Exit 5Y).
With the current market price of 38.00 GBP, the upside of Life Science REIT PLC is
-9.20%.
The range of the Intrinsic Value is 17.74 - 72.27 GBP
34.51 GBP
Intrinsic Value
LABS.L Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| DCF (Growth 5y) |
17.74 - 72.27 |
34.51 |
-9.2% |
| DCF (Growth 10y) |
16.81 - 62.17 |
30.85 |
-18.8% |
| DCF (EBITDA 5y) |
32.13 - 43.35 |
40.80 |
7.4% |
| DCF (EBITDA 10y) |
29.00 - 41.58 |
37.54 |
-1.2% |
| Fair Value |
-57.50 - -57.50 |
-57.50 |
-251.32% |
| P/E |
(72.68) - (86.02) |
(86.25) |
-327.0% |
| EV/EBITDA |
6.14 - 34.31 |
21.55 |
-43.3% |
| EPV |
(22.52) - (20.74) |
(21.63) |
-156.9% |
| DDM - Stable |
(91.13) - (234.37) |
(162.75) |
-528.3% |
| DDM - Multi |
(69.40) - (139.75) |
(92.85) |
-344.3% |
LABS.L Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
132.31 |
| Beta |
-0.04 |
| Outstanding shares (mil) |
3.48 |
| Enterprise Value (mil) |
243.87 |
| Market risk premium |
5.98% |
| Cost of Equity |
10.12% |
| Cost of Debt |
5.00% |
| WACC |
7.82% |